The European Standards of Care for Newborn Health (ESCNH) are financially supported by the following industry partners. Industry partners have no influence on the content of the standards.
If you wish to learn more about an industry partner, please click on the link in the logo.
AstraZeneca is a global, science-led biopharmaceutical company that focuses
on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Baxter has been assisting clinicians in treating patients’ diverse nutrient needs since the 1940s when the company first introduced liquid proteins in the form of amino acids. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. As an example, Baxter pioneered the world’s first triple-chamber system internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the preparation of PN for patients.
Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labelling, compounding technology and enteral nutrition syringes and accessories. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations for new standards of care.
GE Healthcare is a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services.
With over 100 years of experience and leadership in the healthcare industry and more than 50,000 employees globally, GE Healthcare helps healthcare providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.
The Nestlé Nutrition Institute (NNI) shares leading science-based information and education with health professionals, scientists and nutrition communities and stakeholders in an interactive way. As well as being a large publisher of nutritional papers and journals, the NNI organises and hosts internationally acclaimed workshops and symposia, making their findings available worldwide. It provides accredited continuing education programs for a wide range of healthcare professionals including doctors, nurses, midwifes and dietitians. By sharing neutral science-based information and education for healthcare professionals, the Institute fosters Science for Better Nutrition to contribute to the enhancement of the quality of people’s lives all over the world.
Prolacta Bioscience® Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. Prolacta is the world’s leading hospital provider of 100% human milk-based nutritional products that are changing the standard of care for extremely premature infants. In addition, the company is exploring the therapeutic potential of human milk across a wide spectrum of human diseases, including applications for infants requiring surgery for congenital cardiac and gastrointestinal disorders. Operating the world’s first pharmaceutical-grade human milk processing facilities, Prolacta leads the industry with the highest quality and safety standards for the screening and testing of donor milk. Prolacta is a global company with headquarters in Duarte, California.
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Thanks to AbbVie for supporting the project from 2013 until 2020.
Thanks to Takeda for supporting the project from 2019 until 2020.
Thanks to Dräger for supporting the project from 2013 until 2015.
Thanks to Shire for supporting the project from 2014 until 2018.
Thanks to Philips Avent for supporting the project from 2014 until 2019.
Thanks to Philips for supporting the project from 2018 until 2019.
We thank all our industry partners for supporting the ESCNH.